Biomarkers are key indicators for pharmaceutical companies in determining which types of drugs to develop for various ...
June 13, 2008 - Codonics brought to SNM 2008, the Virtua Medical Disc Publisher, designed to set a new standard for ...
Researchers are using speckle tracking imaging in heart ultrasound to monitor the health of transplant acceptance, and ...
Radiology departments have many different needs and face a wide variety of challenges that can impact their departments ...
June 10, 2008 - The Virginia Commonwealth University Health System (VCU) recently implemented McKesson’s Horizon Medical ...
June 10, 2008 – The design of the University of Chicago Medical Center’s New Hospital Pavilion offers flexibility by ...
Cook Medical's FDA-cleared Evolution Controlled Release Esophageal Stent System is a stent designed to improve the quality of life for patients with esophageal cancer.
Despite decades of progress in breast imaging, one challenge continues to test even the most skilled radiologists ...
June 10, 2008 - The use of ultrasound contrast agents during stress echocardiograms is safe, according to results ...
June 10, 2008 – MEDSEEK, a provider of enterprise portal management solutions, said today it is supporting Microsoft ...
Could the treatment of Alzheimer’s disease one day become as routine as treating high cholesterol?
Bayer Radiology’s Barbara Ruhland and Thom Kinst discuss how radiology departments can address the many different ...
June 13, 2008 - The FDA granted tentative approval for Covidien’s Abbreviated New Drug Application (ANDA) for its Kit ...
Toshiba Teli America introduced the T24MSA001-MD medical-grade 24-inch LCD color widescreen monitor with full HD (1,080 ...
ProHance is a macrocyclic, nonionic, gadolinium-based magnetic resonance imaging (MRI) contrast agent designed for use in MRI in adults and children over two years of age to visualize lesions with abnormal vascularity in the brain (intracranial lesions), spine and associated tissues. ProHance is also indicated for use in MRI in adults to visualize lesions in the head and neck.
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
June 9, 2008 - Cardinal Health today launched a new system that leverages the company’s dispensing technologies to ...
The FDA granted tentative approval for Covidien’s Abbreviated New Drug Application (ANDA) for its Kit for the Preparation of Technetium Tc 99m Sestamibi Injection. Covidien’s tentatively approved product is a generic of Cardiolite, which is a myocardial perfusion imaging agent used for detecting coronary artery disease.
The Deficit Reduction Act of 2005 (DRA), which went into effect on January 1, 2007, has left its mark on hospitals and ...
June 9, 2008 - The FDA cleared Mindray’s DC-3 color ultrasound imaging system, equipped with extensive applications in ...
The FDA recently approved Covidien’s contrast delivery system with radiofrequency identification (RFID) technology ...
The EmpowerMR injector system has multiple features created to cope with the problem of electrical interference in the ...
June 9, 2008 - Hologic Inc. said today that it has signed a definitive agreement to acquire Third Wave Technologies Inc ...
June 9, 2008 - Curlin Medical was recently awarded a three-year contract to provide its advanced pain management-local ...
June 09, 2008 